32名の方が先月見積もりをリクエストしました
Mustafa Solak
- 5 優秀 • 1 レビュー
- 20年の経験
- 所在地: トルコ, イスタンブール
ハジェテペ大学癌研究所およびMDアンダーソンがんセンターでの研修を経て、肉腫の放射線療法を専門としています。
- 乳がん、肺がん、消化器がんを含む複雑な症例を担当
- 米国の主要がんセンター(MDアンダーソン)でフェローシップ研修を修了
- 学術的知識と臨床実践経験を融合させたアプローチを実践
- 続きを読む
トルコのトップ放射線療法医師と価格を比較。こちらで最適なマッチングを見つけてください
ご要望と予算に基づいて最適な医師を厳選いたします
医学的監修者 Fahad Mawlood
医学編集者・データサイエンティストトップ医師
17
トルコ
レビュー
14000+
実際の患者より
トップ各国の放射線療法価格を比較
国をタップしてトップ医師と価格を表示
最も人気の範囲
$5K
$7.5K+
$10K+
$12.5K+
$15K+
$17.5K+
$20K+
$22.5K+
$2,300 – $7,200
ほとんどの患者がこの範囲内でお支払いです
正確な費用は選択された医師、技術、治療部位、お客様の個別ニーズによって決まります
お客様のケースに正確な見積もりを取得
個別化された治療計画を無料で取得し、最良のオプションを選択してください。コミットメント不要 · サービス料金なし
最初に表示:
32名の方が先月見積もりをリクエストしました
ハジェテペ大学癌研究所およびMDアンダーソンがんセンターでの研修を経て、肉腫の放射線療法を専門としています。
Dr. Banu Atalar is a board-certified radiation oncologist (Türkiye, 2004). She is a Full Professor at Acibadem MAA University (2018–present) and a clinician at Anadolu Medical Center (2026–present). She trained at Istanbul and Cerrahpaşa. In 2011, she completed a Stanford clinical research fellowship in stereotactic radiosurgery. Her practice focuses on CNS, thoracic, and GI tumors. About 75% of her care involves SRS and MR‑guided adaptive SRS.
Her honors include the ASCO IDEA award (2004), the IASLC International Mentorship Award (2018), and H.FACR (2025). She has 72 international peer‑reviewed publications. Her leadership roles include President of the Turkish Society for Radiation Oncology (2025–27) and Chair of the ESTRO National Societies Committee (2024–27). She served on the ASCO Resource‑Stratified Guidelines Committee (2013–18) and on RSS meeting and nomination committees. She organized national congresses (2023, 2025) and has been an invited speaker at major meetings.
Personal information
Title: Professor Doctor
Branch: Radiation Oncology
Work History:
1 GATA Military Medical Faculty
2 Gayrettepe Florence Nightingale Hospital
3 T.R. Demiroğlu Bilim University \ Associate Professor
4 T.R Demiroğlu Bilim University \ Professor
Medical Specialties and Subspecialties:
1 Head and Neck Cancers
2 Radiation Oncology
Priority treatments:
1 Prostate cancer
2 Conformal treatments
Special advanced health technologies:
1 Truebeam Stx Technology
2 Halcyons
Education
1991 - Istanbul University Istanbul Faculty of Medicine
1996 - Istanbul University Cerrahpaşa Faculty of Medicine Radiation
Oncology Specialization Training
Assoc. Prof. Dr. Oğuzhan BABACAN completed his undergraduate, specialty and sub-specialty education at GATA Military Medical Faculty/Ankara. After becoming a specialist in Pediatrics, he worked in the field of Social Pediatrics for two years, where Healthy Baby Monitoring and vaccine follow-up were carried out. Then, she completed her subspecialty training in Pediatric Hematology and Oncology and continued her studies in the field of pediatric blood and cancer diseases. In addition to the treatment of children suffering from leukemia, lymphoma, solid tumors and other blood diseases, she has been working in the Bone Marrow Transplantation (Transplant) Unit for 13 years in Allogeneic (unrelated and intrafamilial), Autologous (from the patient himself) and Haploidentical (partially HLA compatible) hematopoietic stem cell transplantation. In 2018, he received the title of Associate Professor in the field of Pediatric Hematology and Oncology Science/Art.
MEDICAL AREAS OF INTEREST
Healthy baby follow-up and vaccinations
Lymph node enlargement
Pediatric patients with anemia (anemia)
Leukemia
Lymphoma
Bone Marrow Transplant
ITP
Thalassemias
Hemophiliacs
Solid tumors
Hemangioma
Childhood blood disorders
Children with frequent infections
Fever of unknown origin
Malnutrition in children
Dr. Mehmet Doğu Canoğlu is a radiation oncologist. He graduated from Kocaeli University Faculty of Medicine. He completed his residency in radiation oncology at Kocaeli University from 2006 to 2012.
He completed his compulsory service at Diyarbakır Training and Research Hospital. He then worked at Bağcılar Training and Research Hospital and at Medipol Mega University Hospital from 2015 to 2017. Since 2017, he has been a radiation oncologist at Anadolu Medical Center.
2010 - 2012
M. Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital
2002 - 2010
Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital
1993 - 1998
İ.Ü. Istanbul Faculty of Medicine
Pediatric Hematology and Oncology
この医師は、乳がん、肺がん、消化器系がんの治療を専門とする腫瘍学者です。現在、医師はIstinye Liv University Hospitalで診療を行っています。<\/p>
多くの著名な機関でのキャリアを持ち、医師はMalatya State Hospitalで内科専門医として、Ankara Oncology Clinicで医師として、Erzurum Regional Training and Research Hospitalの腫瘍学部門のメンバーとして勤務してきました。<\/p>
医師はSelcuk Universityの医学部を卒業し、2016年に准教授の称号を取得しました。<\/p>
10名の方が先月見積もりをリクエストしました
Associate Professor Dr. Yusuf AÇIKGÖZ
Specialization: Medical Oncology
Education:
Professional Experience:
Clinical Trials, Courses, Certifications:
Clinical Trials:
Courses:
Certifications:
Memberships:
Dr. Hilmi Apak is a respected pediatric hematology-oncology specialist with more than 21 years of experience. He is trained in pediatric oncology. Dr. Apak has led advanced treatments, including bone marrow transplantation, leukemia chemotherapy, and CAR T-cell therapy.
He has published 75 international medical articles, showing his strong contribution to pediatric oncology research. Dr. Apak has worked as assistant editor for the Turkish Pediatrics Archives Periodical. He has also held important academic and leadership positions, such as Head of Pediatric Hematology-Oncology at Istanbul University-Cerrahpaşa.
メルダン・ファイダ博士はトルコのリヴ病院の放射線腫瘍学者です。博士は4D放射線療法とIMRT、腫瘍の高精度照射を行っています。教授は放射線腫瘍学で19年の経験を持っています。
1993 - 2004年 - ファイダ博士はイスタンブール大学の医学部で学びました。彼はノースカロライナ大学(米国)で放射線外科を学びました。
2012年以降、教授はイスタンブールの癌研究所で実践を続けています。現在、ファイダ教授はトルコで最大の医療ネットワークであるリヴ病院で働いています。
医師は放射線診断を行います:MRI、CT(コンピュータ断層撮影)、PET-CT(陽電子放出断層撮影)。
Bookimedでファイダ博士の相談をリクエストしてください。Bookimedの医師が診断詳細を明らかにするためにご連絡いたします。
メルダン・ファイダ博士は16の国際会議に参加しました。教授はトルコ版で11の科学論文、国際出版で25の論文を執筆しています。
Sema Yılmaz was born on July 30, 1965. She received her undergraduate degree from Istanbul University Cerrahpaşa Medical Faculty and completed her medical residency training at the Department of Pediatrics at Zeynep Kamil Women's and Children's Health and Diseases Hospital. She also completed her medical subspecialty training in Pediatric Hematology/Oncology at Cukurova University. Her medical residency thesis was titled "The Relationship Between Morning First Urine Density and Nocturnal Enuresis in Children Aged 3-6 Years", and her medical subspecialty thesis was titled "Comparison of Sphingosine 1-phosphate Receptor 4 Gene Expression in Healthy Children and Neuroblastoma Patients". She started her medical career as a general practitioner. After working as a general practitioner for 4 years, she worked as a doctor researcher at Zeynep Kamil Women's and Children's Health and Diseases Training and Research Hospital for 5 years. She then served as a specialist doctor, assistant professor, and associate professor at various institutions. She worked at Houston MD Anderson, North Carolina-UNC, Boston-Harvard University in the USA. Additionally, she conducted research on cell therapies. She received the title of professor in Pediatric Hematology/Oncology at Usak Medical Faculty. She is a member of the Turkish Pediatric Oncology Group, European Association for Cancer Research (EACR), Turkish Medical Association, Turkish National Pediatrics Association, Turkish Pediatrics Association, Pediatrics Specialty Academy Association (PUADER), Turkish Immunology Association, Turkish Hematology Association, and Molecular Oncology Association (MOKAD). She currently serves her patients at Koru Hospital. Her medical interests include:
Cell therapies in childhood cancers
Cancer immunology
Investigation of genetic pathways responsible for cancer and metastasis
Pulmonary microbiota
BAL transplantation
海外のクリニックを選ぶことはストレスフルです。800,000名以上の患者をサポートしたBookimedは、お客様の懸念を理解しています。信頼できる医師、最高の価格品質オプション、複雑なケースの解決策を見つける方法を知っています。すべての段階でお客様をご案内いたします。
ヤン・マツィイフスキー
医療コーディネーターチーム責任者
4300+件以上の患者の旅をガイド
Bookimedで3年
Turkeyの278名の患者が今月当社を通じて医師を見つけました
2分のクイズ
目標、予算、スケジュールをお聞かせください
人間のマッチング + AI
アルゴリズムがマッチングを見つけ、コーディネーターが適合性を確認します
オプション準備完了
価格、パッケージ、日程を比較。コーディネーターとチャット
選択肢に迷っていますか?
治療をガイド
医療訓練を受けた専属コーディネーター






| 順位 | 医師 | 経験 | 適合する方 | 特色 | クリニックと所在地 | 診察 |
|---|---|---|---|---|---|---|
| #1 | 20年の経験 | 複合肉腫症例 | MDアンダーソンで研鑽を積み、最先端の米国技術を肉腫治療に導入。精密放射線治療を要する難治性がんを専門とする。 | トルコ | から $100 |
Turkish radiation oncologists specialize in sarcoma treatments by integrating precision technologies with international expertise. Leading specialists often hold fellowships from renowned US institutions like MD Anderson and Stanford. They apply advanced techniques like IMRT and MR-guided radiosurgery to treat complex soft tissue and bone tumors.
Bookimed Expert Insight: Data shows a strong trend of US-Turkish academic exchange among top sarcoma specialists. For instance, Dr. Mustafa Solak and Prof. Sema Yilmaz both brought advanced protocols from MD Anderson Cancer Center to Istanbul. Patients benefit from these North American standards combined with local consultation fees starting from $100.
Patient Consensus: Patients note it is important to find centers where surgeons and radiation oncologists work together on timing and margins. They feel most reassured when doctors explain exactly how they will protect nearby nerves or organs during therapy. Many say focusing on a dedicated sarcoma team is better than just looking for a famous hospital name.
Turkish radiation oncologists typically hold Turkish Board certification rather than US American Board credentials. Many leading specialists complete advanced training at major American institutions. This ensures they apply international protocols for complex sarcoma care at JCI-accredited facilities throughout Turkey.
Bookimed Expert Insight: While local certification is standard, many top Turkish oncologists have significant US research backgrounds. Dr. Sema Yilmaz has conducted cancer research at Harvard and MD Anderson. Patients seeking American-standard care should prioritize doctors with these specific clinical fellowships. These specialists often offer consultations starting from $100.
Patient Consensus: Patients note that verifying the specific doctor who plans the radiation dose is vital. They suggest checking for evidence of specialized fellowship training in the US or Europe. Experience with rare sarcoma types often matters more than general oncology titles.
Turkish radiation oncologists typically review sarcoma cases through multidisciplinary tumor boards. Specialists from radiation oncology sit with surgeons and radiologists to plan care. This team-based approach is a standard at major JCI-accredited centers in Istanbul and Ankara. These panels optimize treatment timing and radiation dosage for complex tumors.
Bookimed Expert Insight: Many leading Turkish oncologists, such as Dr. Mustafa Solak and Dr. Banu Atalar, bring international expertise from institutions like MD Anderson and Stanford. Dr. Atalar currently serves as the President of the Turkish Society for Radiation Oncology. This level of leadership ensures that local tumor boards follow global protocols for rare sarcoma cases. Patients can access expert consultations with these specialists starting from $100.
Patient Consensus: Patients note that a single doctor deciding a plan alone is often a red flag for rare tumors. They emphasize asking if pathology was re-read by a sarcoma specialist during board reviews. Most find that receiving a written recommendation from the entire clinical team provides significant peace of mind.
Turkish radiation oncologists manage side effects using precision technologies like IMRT and MR-Guided Adaptive SRS to spare healthy tissue. Specialists such as Dr. Banu Atalar and Dr. Mehmet Dogu Canoglu provide structured skin care protocols and multidisciplinary monitoring to handle fatigue and toxicity throughout the recovery process.
Bookimed Expert Insight: Data shows that top Turkish radiation specialists often bring expertise from leading US institutions. Dr. Mustafa Solak and Dr. Banu Atalar both completed fellowships at specialized US cancer centers. This results in a follow-up approach where US-standard protocols for long-term toxicity monitoring are effectively integrated into local clinical practice.
Patient Consensus: Patients value receiving clear, written instructions for managing skin burns and fatigue at home. Many noted that the most helpful experience was having a direct way to contact the medical team when side effects changed quickly during the first three weeks.
Turkish radiation oncologists treat bone and soft tissue sarcomas using precise modalities like MR-LINAC and CyberKnife radiosurgery. Specialists like Dr. Mustafa Solak and Dr. Merdan Fayda utilize 4D-radiotherapy to protect blood vessels and nerves. These technologies allow for sub-millimeter accuracy near critical spinal structures.
Bookimed Expert Insight: Many leading Turkish experts bring international experience from top-tier US cancer centers to their practice. For instance, Dr. Mustafa Solak at Hisar Hospital and Prof. Sema Yilmaz at Koru Ankara Hospital both conducted research at MD Anderson Cancer Center. This background helps them apply advanced US-based precision protocols for complex sarcoma cases.
Patient Consensus: Patients note that the ability to visualize the tumor during treatment with MR-LINAC provides significant peace of mind. They emphasize how moving through a 5-day SBRT course felt much more manageable than traditional 8-week schedules. Many also mentioned that having translators at the hospital made these technical procedures much easier to understand.